Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Praxis purchases intellectual property allowing development of antirejection drug

March 4, 1999

Cerus cleared by FDA to begin clinical trials of transplantation system

March 4, 1999

New Vasogen technology protects against GVHD in animal model

Feb. 26, 1999

Israeli authorities approve new indication for WinRho SDF

Feb. 24, 1999

SangStat's Thymoglobulin launched in U.S.

Feb. 22, 1999

Available for licensing from OMRF: diagnostic and therapeutic agents for spondyloarthropathies

Feb. 22, 1999

Second U.S. patent allowed for Antex Biologics' H. pylori vaccine

Feb. 19, 1999

Wyeth-Ayerst seeks European approval of Rapamune

Feb. 18, 1999

Good safety, increased immunogenicity reported for MF59-adjuvanted flu vaccine

Feb. 12, 1999

ID Biomedical and Ribi ImmunoChem to develop E. coli vaccine

Feb. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...